Afamelanotide

Back to search

Molecule Structure

Scientific Name

Afamelanotide

Description of the Drug

Afamelanotide is an injectable subcutaneous implant used to mitigate phototoxicity secondary to erythropoietic protoporphyria (EPP).

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04931

Brand Name(s)

Scenesse

Company Owner(s)

Clinuvel Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Melanocortin receptor 1 SINGLE PROTEIN AGONIST CHEMBL3795

Unichem Links

SureChEMBL SCHEMBL22463810
DrugBank DB04931
PubChem: Thomson Pharma 16681347 16544557
PubChem 91898441 44285019 16154396 57514683 16197727
Nikkaji J313.185H
BindingDB 50017181 82411
EPA CompTox Dashboard DTXSID40226843
ChemicalBook CB4252333
Guide to Pharmacology 1324
rxnorm SCENESSE AFAMELANOTIDE AFAMELANOTIDE ACETATE
ChEBI 136034